Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the prior Notice about government funding lapse and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T14:22:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1. These changes are cosmetic and do not alter the study content.
    Difference
    0.2%
    Check dated 2026-02-04T10:39:43.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Minor UI/text tweaks were made: a glossary display option, capitalization updates for QC-related fields and No FEAR Act data, and a new revision tag (v3.4.0). These edits do not affect study content, eligibility criteria, results, or user workflow.
    Difference
    0.1%
    Check dated 2026-01-28T06:17:17.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.3.4 and removed Revision v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T02:39:37.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Locations section updated: new sites across the US, Australia, and Canada were added and previous site entries were removed, altering the list of participating sites for the study. Revision: v3.3.3.
    Difference
    3%
    Check dated 2025-12-23T10:32:51.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing v3.3.1 in the page footer; the change is cosmetic and does not affect the study content or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:39:06.000Z thumbnail image

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.